PARALLAX (Completed)
A 24-week, study to evaluate the effect of LCZ696 on NT-proBNP, symptoms, exercise function and safety compared to individualized medical management of comorbidities in patients with heart failure and preserved ejection fraction
- Medicine
- Entresto
- Population
- Heart failure
- Phase
- III
- Starting year
- 2017
- More information
- Clinicaltrials.gov